Plain-English translation of NCT05547529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is comparing two different treatment approaches for people with advanced esophageal cancer that can be surgically removed. One group receives chemotherapy combined with radiation therapy before surgery, while the other group receives chemotherapy alone before surgery. The study wants to see which approach works better at helping patients recover and live longer after their operation.
For people with advanced esophageal cancer, doctors currently use chemotherapy before surgery to shrink the tumor and improve outcomes. However, researchers believe that adding radiation therapy to the chemotherapy might work even better, and this trial will find out if that's true.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either chemotherapy with radiation or chemotherapy alone, both given before your esophageal surgery. The chemotherapy treatment takes several weeks, and radiation (if assigned to that group) is given alongside it. After completing the pre-surgery treatment, you will have your esophagus surgically removed. Throughout the trial, you'll have regular checkups, blood tests, and imaging scans to monitor how well the treatment is working and how you're doing.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Russia